Table 3.
Marine pharmacology in 2001 – 2002: marine compounds with miscellaneous mechanisms of action
Compound/organisma | Chemistry | Pharmacological activity | MMOAb | Countryc | References |
---|---|---|---|---|---|
Aeroplysinin-1 (76)/sponge | Amino acid derivedd | Antiangiogenic | Undetermined | SPA | Rodriguez-Nieto et al., 2002 |
Antillatoxin (77)/bacterium | Lipopeptided | Voltage-dependent Na+ channel activation | Sodium channel α subunit binding | JAPN, USA | Li et al., 2001 |
Aplysiallene (78)/sea hare | Polyketidee | Na+, K+ – ATPase inhibition | Undetermined | JAPN | Okamoto et al., 2001a |
Azaspiracid-1 (79)/alga | Polyketidee | Toxicity to lymphocytes and neuroblastoma cells | Decrease in F-actin pools and increased [Ca2+]i | SPA, JAPN | Roman et al., 2002 |
Bistratene A (80)/ascidian | Polyketidee | Induction of cell-cycle arrest in Go/G1 and G2/M | Protein kinase C δ activation | AUS, USA | Frey et al., 2001 |
Bryoanthrathiophene (81)/bryozoa | Polyketidee | Angiogenesis inhibition | Undetermined | JAPN | Jeong et al., 2002 |
Bryostatin-1 (82)/bryozoa | Polyketidee | IgE synthesis inhibition | Iε germline transcription modulation | USA | Rabah et al., 2001 |
Coscinosulfate (83)/sponge | Sesquiterpenef | Cell cycle regulation | Dual specificity phosphatase CDC25 inhibition | FRA | Loukaci et al., 2001 |
Debromohymenialdisine (84)/sponge | Alkaloidd | G2 checkpoint inhibition | Protein kinase Chk1 and Chk2 inhibition | CAN, UK, USA | Curman et al., 2001 |
Chlorogentisylquinone (85)/fungus | Polyketidee | Neutral sphingomyelinase inhibition | Undetermined | JAPN | Uchida et al., 2001 |
Discodermin A (86)/sponge | Peptided | Permeabilization of plasma membrane | Undetermined | JAPN | Sato et al., 2001 |
Farnesylhydroquinone (87)/fungus | Terpenef | Radical scavenging | Undetermined | S. KOR | Son et al., 2002 |
Halenaquinol (88)/sponge | Polyketide | Na+, K+ – ATPase inhibition | Oxidation of sulfhydryl groups | RUS | Gorshkova et al., 2001 |
Halenaquinone (89)/sponge | Polyketidee | Induction of apoptosis | Inhibition of phosphatidyl inositol 3-kinase | JAPN | Fujiwara et al., 2001 |
Hectochlorin (90)/bacterium | Peptided | Inhibition of cell growth | Induction of actin polymerization | USA | Marquez et al., 2002 |
Iantherans A and B (91 and 92)/sponge | Peptided | Na+, K+ – ATPase and plasmin inhibition | Undetermined | JAPN | Okamoto et al., 2001b |
Jaspaquinol (93)/sponge | Terpenef | Human 15-lipoxygenase inhibition | Undetermined | USA | Carroll et al., 2001 |
Jasplankinolide (39)/sponge | Peptide/Polyketidee | Increased outflow facility in monkey eye | Undetermined | USA | Tian et al., 2001 |
Linckosides A and B (94 and 95)/starfish | Sterol glycosidef | Induction of neuritogenesis | Undetermined | JAPN | Qi et al., 2002 |
Maitotoxin (96)/alga | Complex polyketidee | Modulation of calcium and sodium influx | Undetermined | MEX | Morales-Tlalpan and Vaca, 2002 |
Complex polyketidee | Regulation of excocytosis in Xenopus laevis oocytes | Activation of cation conductance | GER, RUS, UK, FRA | Diakov et al., 2001 | |
Micropeptins (97)/bacterium | Depsipeptidesd | Inhibition of trypsin and chymotrypsin | Undetermined | ISRA | Reshef and Carmeli, 2001 |
Pectenotoxin-6 (98)/alga | Macrolidee | Disruption of F-actin cytoskeletal | Induction of F-actin depolymerization | SPA, JAPN, ITA | Leira et al., 2002 |
Sculezonone-A and B (99 and 100)/fungus | Polyketidee | Inhibition of DNA polymerase α, β and γ | Differential electrostatic charges elicit different inhibition spectra | JAPN | Perpelescu et al., 2002 |
Scytonemin (61)/bacterium | Amino acidd | Inhibition of active cell proliferation | Inhibition of polo-like and cell-cycle kinases | USA | Stevenson et al., 2002a |
Stolonoxides (101)/tunicate | Fatty acide | Mitochondrial respiratory chain inhibition | Effect on mitochondrial complex II and III | ITA, SPA | Fontana et al., 2001 |
Swinholide A (102)/sponge | Complex Polyketidee | Increased outflow facility in monkey eye | Undetermined | USA | Tian et al., 2001 |
Wondonins A and B (103 and 104)/sponge | Alkaloidd | Modulation of angiogenesis in vitro | Undetermined | S. KOR | Shin et al., 2001 |
Xetospongin-C (105)/sponge | Alkaloidd | Inhibition of smooth muscle contraction | Voltage-dependent K+ and L-type Ca2+ channel inhibition | JAPN | Ozaki et al., 2002 |
Yessotoxin (106)/alga | Polyketidee | Lymphocyte [Ca2+]i homeostasis modulation | Inhibition of calcium channels | SPA | De la Rosa et al., 2001 |
Organism, Kingdom Animalia: ascidians and tunicates (Phylum Chordata), anemones, corals and hydroids (Phylum Cnidaria), sea cucumber and starfish (Phylum Echinodermata), bryozoa (Phylum Ectoprocta), sea hares (Phylum Mollusca), and sponge (Phylum Porifera); Kingdom Fungi: fungus; Kingdom Plantae: alga; and Kingdom Monera: bacterium (Phylum Cyanobacteria).
MMOA: molecular mechanism of action.
Country: AUS: Australia; CAN: Canada; CHI: China; FRA: France; GER: Germany; ISRA: Israel; ITA: Italy; JAPN: Japan; MEX: Mexico; RUS: Russia; S. KOR: South Korea; SPA: Spain; and UK: United Kingdom.
Nitrogen-containing compounds.
Polyketides.
Terpenes.
Polysaccharides.